{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:46:44Z","timestamp":1761518804958,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.breast.2005.03.006","type":"journal-article","created":{"date-parts":[[2005,7,12]],"date-time":"2005-07-12T16:13:10Z","timestamp":1121184790000},"page":"97-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Potential role of chemo-radiation with oral capecitabine in a breast cancer patient with central nervous system relapse"],"prefix":"10.1016","volume":"15","author":[{"given":"Hajime","family":"Hikino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takako","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanta","family":"Johbara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiko","family":"Obayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2005.03.006_bib1","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1002\/1097-0142(19941215)74:12<3135::AID-CNCR2820741212>3.0.CO;2-8","article-title":"Carcinomatous meningitis in patients with breast cancer. An aggressive disease variant","volume":"74","author":"Jayson","year":"1994","journal-title":"Cancer"},{"year":"1995","author":"Posner","series-title":"Neurologic complications of cancer","key":"10.1016\/j.breast.2005.03.006_bib2"},{"key":"10.1016\/j.breast.2005.03.006_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1023\/A:1011132609055","article-title":"High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel","volume":"12","author":"Crivellari","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2005.03.006_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1023\/A:1005956925637","article-title":"Current diagnosis and treatment of leptomeningeal metastasis","volume":"38","author":"DeAngelis","year":"1998","journal-title":"J Neurooncol"},{"key":"10.1016\/j.breast.2005.03.006_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11912-003-0085-8","article-title":"Toxicity of treatment for neoplastic meningitis","volume":"5","author":"Siegal","year":"2003","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.breast.2005.03.006_bib6","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1764::AID-CNCR24>3.0.CO;2-1","article-title":"Leptomeningeal metastases from solid tumors: a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy","volume":"82","author":"Bokstein","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2005.03.006_bib7","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0959-8049(98)00058-6","article-title":"Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue","volume":"34","author":"Miwa","year":"1998","journal-title":"Eur J Cancer"},{"issue":"Suppl. 6","key":"10.1016\/j.breast.2005.03.006_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1634\/theoncologist.7-suppl_6-1","article-title":"Incorporating oral capecitabine into the treatment of breast cancer. Introduction","volume":"7","author":"Seidman","year":"2002","journal-title":"Oncologist"},{"key":"10.1016\/j.breast.2005.03.006_bib9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1200\/JCO.1999.17.2.485","article-title":"Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer","volume":"17","author":"Blum","year":"1999","journal-title":"J Clin Oncol"},{"unstructured":"McEvoy GK, editor. Capecitabine. In: AHFS drug information. Bethesda, MD: American Society of Health-System Pharmacists; 2002. p. 916\u201321.","key":"10.1016\/j.breast.2005.03.006_bib10"},{"key":"10.1016\/j.breast.2005.03.006_bib11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1600-0404.1986.tb07862.x","article-title":"Passage of 5\u2032-dFUrd and its metabolites 5-FU and 5-FUH2 to CSF in a clinical phase 1 study","volume":"74","author":"Heier","year":"1986","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.breast.2005.03.006_bib12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00000421-200108000-00026","article-title":"Capecitabine for 5-fluorouracil-resistant brain metastases from breast cancer","volume":"24","author":"Wang","year":"2001","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.breast.2005.03.006_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/B:NEON.0000003752.89814.ca","article-title":"Response of neoplastic meningitis from solid tumors to oral capecitabine","volume":"65","author":"Giglio","year":"2003","journal-title":"J Neurooncol"},{"key":"10.1016\/j.breast.2005.03.006_bib14","first-page":"63","article-title":"Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy","volume":"6","author":"Rogers","year":"2004","journal-title":"Neurooncology"},{"key":"10.1016\/j.breast.2005.03.006_bib15","first-page":"833","article-title":"Complete response of brain metastases originating in breast cancer to capecitabine therapy","volume":"5","author":"Siegelmann-Danieli","year":"2003","journal-title":"Isreal Med Assoc J"},{"key":"10.1016\/j.breast.2005.03.006_bib16","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0009-9260(99)91181-9","article-title":"Imaging features of leptomeningeal metastases","volume":"54","author":"Collie","year":"1999","journal-title":"Clin Radiol"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977605000846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977605000846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:22:25Z","timestamp":1760775745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977605000846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0960977605000846"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2005.03.006","relation":{},"ISSN":["0960-9776"],"issn-type":[{"type":"print","value":"0960-9776"}],"subject":[],"published":{"date-parts":[[2006,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential role of chemo-radiation with oral capecitabine in a breast cancer patient with central nervous system relapse","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2005.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}